Louis Kenneth Zweig, MD | |
3833 N Fairfax Drive, Suite 200, Arlington, VA 22203 | |
(703) 525-8863 | |
(703) 525-2387 |
Full Name | Louis Kenneth Zweig |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 26 Years |
Location | 3833 N Fairfax Drive, Arlington, Virginia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1730197591 | NPI | - | NPPES |
P00255198 | Other | RR MEDICARE | |
010171270 | Medicaid | VA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 0101227887 (Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Virginia Hospital Center | Arlington, VA | Hospital |
Inova Alexandria Hospital | Alexandria, VA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Inova Health Care Services | 2466351093 | 1725 |
Northern Virginia Family Practice Associates | 6800872433 | 8 |
News Archive
The American Society of Anesthesiologists (ASA) today joins Americans across the nation to recognize Doctors' Day 2012, an observance to celebrate the contributions of physicians.
A PIONEERING new stem cell treatment ‘rebooting' the immune system in some multiple sclerosis sufferers is being hailed as an encouraging step forward in the treatment of the disease in sufferers who fail to respond to standard therapies.
About 10 percent of patients with chronic lymphocytic leukemia (CLL) discontinued therapy with the Bruton tyrosine kinase (BTK) inhibitor drug ibrutinib because of disease progression during clinical trials, according to a study published online in JAMA Oncology.
A special report in the April 19, 2007 edition of The New England Journal of Medicine concludes that the sharp decline in breast-cancer incidence in 2003, followed by a relative stabilization at a lower rater in 2004, is most likely related to the first report of the Women's Health Initiative (WHI).
› Verified 8 days ago
Entity Name | General Internal Medicine Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1497856793 PECOS PAC ID: 6507857190 Enrollment ID: O20040521000769 |
News Archive
The American Society of Anesthesiologists (ASA) today joins Americans across the nation to recognize Doctors' Day 2012, an observance to celebrate the contributions of physicians.
A PIONEERING new stem cell treatment ‘rebooting' the immune system in some multiple sclerosis sufferers is being hailed as an encouraging step forward in the treatment of the disease in sufferers who fail to respond to standard therapies.
About 10 percent of patients with chronic lymphocytic leukemia (CLL) discontinued therapy with the Bruton tyrosine kinase (BTK) inhibitor drug ibrutinib because of disease progression during clinical trials, according to a study published online in JAMA Oncology.
A special report in the April 19, 2007 edition of The New England Journal of Medicine concludes that the sharp decline in breast-cancer incidence in 2003, followed by a relative stabilization at a lower rater in 2004, is most likely related to the first report of the Women's Health Initiative (WHI).
› Verified 8 days ago
Entity Name | Northern Virginia Family Practice Associates |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1992869689 PECOS PAC ID: 6800872433 Enrollment ID: O20040625000089 |
News Archive
The American Society of Anesthesiologists (ASA) today joins Americans across the nation to recognize Doctors' Day 2012, an observance to celebrate the contributions of physicians.
A PIONEERING new stem cell treatment ‘rebooting' the immune system in some multiple sclerosis sufferers is being hailed as an encouraging step forward in the treatment of the disease in sufferers who fail to respond to standard therapies.
About 10 percent of patients with chronic lymphocytic leukemia (CLL) discontinued therapy with the Bruton tyrosine kinase (BTK) inhibitor drug ibrutinib because of disease progression during clinical trials, according to a study published online in JAMA Oncology.
A special report in the April 19, 2007 edition of The New England Journal of Medicine concludes that the sharp decline in breast-cancer incidence in 2003, followed by a relative stabilization at a lower rater in 2004, is most likely related to the first report of the Women's Health Initiative (WHI).
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Louis Kenneth Zweig, MD 3022 Williams Drive, Suite 300, Fairfax, VA 22031 Ph: (703) 573-9800 | Louis Kenneth Zweig, MD 3833 N Fairfax Drive, Suite 200, Arlington, VA 22203 Ph: (703) 525-8863 |
News Archive
The American Society of Anesthesiologists (ASA) today joins Americans across the nation to recognize Doctors' Day 2012, an observance to celebrate the contributions of physicians.
A PIONEERING new stem cell treatment ‘rebooting' the immune system in some multiple sclerosis sufferers is being hailed as an encouraging step forward in the treatment of the disease in sufferers who fail to respond to standard therapies.
About 10 percent of patients with chronic lymphocytic leukemia (CLL) discontinued therapy with the Bruton tyrosine kinase (BTK) inhibitor drug ibrutinib because of disease progression during clinical trials, according to a study published online in JAMA Oncology.
A special report in the April 19, 2007 edition of The New England Journal of Medicine concludes that the sharp decline in breast-cancer incidence in 2003, followed by a relative stabilization at a lower rater in 2004, is most likely related to the first report of the Women's Health Initiative (WHI).
› Verified 8 days ago
Dr. Alvaro Andres Puig Rodriguez, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1625 N George Mason Dr Ste 425, Arlington, VA 22205 Phone: 703-717-4400 | |
Tiffany C Turner, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1625 N George Mason Dr Ste 345, Arlington, VA 22205 Phone: 703-717-4400 Fax: 703-717-4401 | |
Dr. Anne Ruggles Pariser, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2921 11th St S, Arlington, VA 22204 Phone: 703-979-1400 | |
Dr. Michael Andrew Cole, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1701 N George Mason Dr, Intensive Care Unit, Arlington, VA 22205 Phone: 571-244-8410 | |
Robert Paul Holman, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1635 N George Mason Dr, Suite 180, Arlington, VA 22205 Phone: 703-276-7798 Fax: 703-276-0433 | |
Dr. Irmindra S Rana, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 611 S Carlin Springs Rd, Suite 301, Arlington, VA 22204 Phone: 703-998-0480 Fax: 703-379-0449 | |
Dr. Ashok Chauhan, M.D., Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 611 S Carlin Springs Rd, Suite 511, Arlington, VA 22204 Phone: 703-379-4446 Fax: 703-379-0449 |